These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 4782089)

  • 1. [Glipizide, a new sulfonylurea in the treatment of diabetes mellitus].
    Villaseñor A
    Prensa Med Mex; 1973; 38(5):211-4. PubMed ID: 4782089
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of a new sulfonylurea, glipizide, in the treatment of diabetes mellitus].
    Ninni M; Castelletta L
    Minerva Med; 1973 Oct; 64(71):3725-31. PubMed ID: 4588364
    [No Abstract]   [Full Text] [Related]  

  • 3. Glipizide, a new sulfonylurea in the treatment of diabetes mellitus. Summary of clinical experience in 1064 cases.
    Emanueli A; Molari E; Pirola LC; Caputo G
    Arzneimittelforschung; 1972 Nov; 22(11):1881-5. PubMed ID: 4267009
    [No Abstract]   [Full Text] [Related]  

  • 4. A controlled clinical trial of a new oral hypoglycemic agent, glipizide (K 4024).
    Lentini S; Bossini A; Pirola LC
    Arzneimittelforschung; 1972 Jul; 22(7):1169-73. PubMed ID: 4678124
    [No Abstract]   [Full Text] [Related]  

  • 5. [New oral hypoglycemic agent: K 4024 or glipizide. Clinical trial].
    Angeli G; Baraldi B; Tiraboschi L; Caputo G
    Clin Ter; 1972 Dec; 63(5):438-52. PubMed ID: 4566419
    [No Abstract]   [Full Text] [Related]  

  • 6. Modifications of glycemia and insulinemia in diabetics treated with glipizide (K 4024), a new sulfonylurea.
    Fedele D; Tiengo A; Riva F; Muggeo M; Emanueli A; Crepaldi G
    Arzneimittelforschung; 1972 Nov; 22(11):1885-8. PubMed ID: 4679060
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical experimentation with a new hypoglycemic agent (glipizide)].
    Forattini C
    Minerva Med; 1972 Oct; 63(70):3816-21. PubMed ID: 4562437
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical and metabolic observations with a new synthetic oral antidiabetic agent, glipizide.
    D'Onofrio F; Pempinello R; Romis L
    Arzneimittelforschung; 1972 Nov; 22(11):1879-81. PubMed ID: 4679059
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical trial of glypizide].
    Cañadell Vidal J
    Rev Iber Endocrinol; 1974 Jan; 21(121):61-73. PubMed ID: 4826383
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of glipizide on a double-meal test in diabetic patients.
    Vailati G; Pagani G; Montini M; Caputo G; Sacchetti G
    Arzneimittelforschung; 1972 Nov; 22(11):1888-9. PubMed ID: 4679061
    [No Abstract]   [Full Text] [Related]  

  • 11. Glipizide versus tolbutamide in maturity-onset diabetes, an open comparative study.
    Fuchs K
    Diabetologia; 1973 Sep; ():351-5. PubMed ID: 4772980
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical evaluation of glypidizine, a new oral hypoglycemic agent].
    Domingo Gutiérrez AJ; Fernández-Cruz A
    Rev Iber Endocrinol; 1973; 20(117):289-303. PubMed ID: 4581992
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical study with glipizide, a new oral antidiabetic drug.
    Persson G
    Diabetologia; 1973 Sep; ():348-50. PubMed ID: 4589635
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical experience with glipizide in the treatment of mostly complicated diabetes.
    Masbernard A; Giudicelli C; Massey J
    Diabetologia; 1973 Sep; ():356-63. PubMed ID: 4772981
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacological and clinical evaluation of the activity and tolerance of a new oral antidiabetic compound, glydiazinamide or K 4024.
    Parodi FA
    Isr J Med Sci; 1972 Jun; 8(6):888-92. PubMed ID: 5051831
    [No Abstract]   [Full Text] [Related]  

  • 16. [Glydiazinamide-induced changes in the oral glucose tolerance of 15 adult diabetics].
    Vailati G; Montini M; Pagani G; Caputo G
    Minerva Med; 1972 Oct; 63(69):3752-7. PubMed ID: 5078667
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of diabetes with low doses of glypizide].
    Lozano-Castañeda O; Schulte J; Gonzálex Barranco J; García Viveros M; Rull JA
    Prensa Med Mex; 1974; 39(7-8):358-61. PubMed ID: 4453534
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical evaluation of glidiazinamide].
    Pedrazzi F; Bommartini F
    G Gerontol; 1972 May; 20(5):459-67. PubMed ID: 4626363
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapeutic trial of a new antidiabetic with vascular action: 1702 SE].
    Jaillard J; Warembourg H
    Lille Med; 1972 Oct; 17(9):Suppl 6:1332-6. PubMed ID: 4657429
    [No Abstract]   [Full Text] [Related]  

  • 20. Long term treatment of diabetes mellitus with glibornuride. A new hypoglycemic agent.
    Nava M; Quibrera R; Pérez Arocha N
    Rev Invest Clin; 1973; 25(2):169-74. PubMed ID: 4198609
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.